Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Publication year range
1.
Autoimmunity ; 42(1): 25-32, 2009 Jan.
Article in English | MEDLINE | ID: mdl-18608175

ABSTRACT

Rheumatoid arthritis is an autoimmune disease that affects human beings worldwide. Infections have been associated to autoimmune diseases because their ability to induce a dominant cytokine response. Joint inflammation has been related to Th1 response because they induce high expression of proinflammatory cytokines TNF-alpha, IL-1, IFN-gamma. MRL/lpr mice spontaneously develop an autoimmune disease affecting joints, kidneys, etc. We compared incidence and severity of arthritis, antibody response, cytokine production, in mice infected with bacteria or helminthes in the Murphy Roths Large (MRL)lpr mice. Infections with helminthes Heligmosomoides polygyrus, Nippostrongylus brasiliensis or bacteria Nocardia brasiliensis and Staphylococcus aureus were studied. IL-4, IFN-gamma and IgG1, IgG2a antibody productions were determined. IFN-gamma was increased in all groups, the highest production was observed after bacterial infection; IL-4 production was higher after helminthes infection. IgG1 sera levels were increased in the helminthes infected group. IgG2a sera concentration was stimulated by bacterial infection. The histopathology showed that 100% of bacterial infected mice developed arthritis and severe tissue damage such as cartilage erosion and bone destruction. Animals infected with parasites showed a decreased incidence and severity of arthritis. Severity of tissue damage in joints is correlated with increased numbers of lymphocytes and macrophages immunoreactive to proinflammatory cytokines.


Subject(s)
Arthritis, Experimental/physiopathology , Arthritis, Rheumatoid/physiopathology , Nippostrongylus/immunology , Staphylococcal Infections , Staphylococcus aureus/immunology , Strongylida Infections , Animals , Antibodies, Bacterial/blood , Antibodies, Helminth/blood , Arthritis, Experimental/immunology , Arthritis, Rheumatoid/immunology , Cytokines/metabolism , Disease Models, Animal , Female , Humans , Mice , Mice, Inbred MRL lpr , Nippostrongylus/pathogenicity , Severity of Illness Index , Staphylococcal Infections/immunology , Staphylococcal Infections/microbiology , Staphylococcal Infections/physiopathology , Staphylococcus aureus/metabolism , Staphylococcus aureus/pathogenicity , Strongylida Infections/immunology , Strongylida Infections/physiopathology , Th1 Cells/immunology
2.
Crit Rev Clin Lab Sci ; 40(2): 117-49, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12755453

ABSTRACT

Acute pancreatitis is a disorder that affects approximately 200,000 individuals in the U.S. annually. While most cases are mild, up to 30% of patients will have a complicated course with prolonged hospitalization and significant morbidity and mortality. Early institution of several therapeutic interventions, such as enteral nutrition, prophylactic antibiotics, endoscopic retrograde cholangiopancreatography (ERCP) and intensive care monitoring, have been shown to decrease the morbidity associated with severe acute pancreatitis. However, the ability of clinicians to predict, upon presentation, which patient will have mild or severe pancreatitis has remained poor over the years, thus leading to a delay in the institution of such treatments. Researchers have focused on markers that might improve upon clinical prediction alone. While data have shown the predictive value of tools such as Ranson's and Glasgow's criteria, C-reactive protein (CRP) and the APACHE score, their application in clinical practice has been limited by a time delay of at least 48 h in the former two and by being cumbersome in the latter. Thus, our focus is to critically appraise the evidence available for various biochemical markers in their ability to distinguish mild and severe acute pancreatitis early and more accurately than currently available tools.


Subject(s)
C-Reactive Protein/analysis , Cytokines/analysis , Oligopeptides/analysis , Pancreatitis, Acute Necrotizing/classification , Pancreatitis, Acute Necrotizing/diagnosis , Severity of Illness Index , Trypsinogen/analysis , APACHE , Biomarkers/analysis , Female , Health Status Indicators , Humans , Male , Pancreatitis, Acute Necrotizing/blood , Pancreatitis, Acute Necrotizing/urine , Predictive Value of Tests , Reproducibility of Results , Sensitivity and Specificity
3.
Rev. mex. reumatol ; 16(5): 349-353, sept.-oct. 2001. ilus
Article in Spanish | LILACS | ID: lil-314430

ABSTRACT

El síndrome antifosfolípido (SAF) se caracteriza por eventos trombóticos venosos y arteriales, abortos recurrentes, manifestaciones neurológicas y anticuerpos anticardiolipina. Estos últimos pueden estar asociados a enfermedades de tejido conectivo, infecciones, neoplasias y drogas. Sin embargo, la mayoría de las veces no son trombogénicos. Presentamos el caso de un paciente masculino de 52 años con un carcinoma epitelial metastásico a médula ósea con manifestaciones neurológicas, trombóticas y resológicas de SAF.


Subject(s)
Humans , Male , Middle Aged , Neoplasms, Unknown Primary , Bone Marrow/pathology , Antiphospholipid Syndrome/diagnosis , Carcinoma , Antibodies, Anticardiolipin , Neoplasm Metastasis
SELECTION OF CITATIONS
SEARCH DETAIL
...